Skip to main content
Top
Published in: European Journal of Nutrition 5/2019

01-08-2019 | Original Contribution

Interesterified palm olein lowers postprandial glucose-dependent insulinotropic polypeptide response in type 2 diabetes

Authors: Shuen-Yeing Mo, Oi-Ming Lai, Boon-How Chew, Ruhaini Ismail, Sallehudin Abu Bakar, Norli Abdul Jabbar, Kim-Tiu Teng

Published in: European Journal of Nutrition | Issue 5/2019

Login to get access

Abstract

Purpose

We aim to investigate the postprandial effects of palm olein (PO) and chemically interesterified palm olein (IPO) with different proportions of palmitic acid at the sn-2 position using high oleic sunflower oil (HOS) as control fat on concentrations of gut hormones, glucose homeostasis, satiety, lipid and inflammatory parameters in type 2 diabetic (T2D) subjects.

Methods

Using a randomised double-blind crossover design, 21 (men = 6, women = 15) T2D subjects consumed test meals (3.65 MJ) consisting of a high fat muffin (containing 50 g test fats provided as PO, IPO or HOS) and a milkshake. Postprandial changes in gut hormones, glucose homeostasis, satiety, lipid and inflammatory parameters after meals were analysed. Some of the solid fractions of the IPO were removed and thus the fatty acid composition of the PO and IPO was not entirely equal (PO vs IPO: palmitate 39.8 vs 38.7; oleate 43.6 vs 45.1). PO, IPO and HOS contained 9.7, 38.9 and 0.2 g/100 g total fatty acids of palmitic acid at the sn-2 position, respectively. At 37 °C, IPO contained 4.2% SFC whereas PO and HOS were completely melted.

Results

Our novel observation shows that the incremental area under curve (iAUC) 0–6 h of plasma GIP concentration was on average 16% lower following IPO meal compared with PO and HOS (P < 0.05) meals. Serum C-peptide concentrations exhibited a significant meal × gender interaction (P = 0.009). No differences between test meals were noted for other measurements.

Conclusions

This study shows no adverse effect of interesterification on hormones associated with glucose homeostasis notably GLP-1 in T2D subjects.

Trial registration

Appendix
Available only for authorised users
Literature
1.
go back to reference DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38(4):387–395CrossRef DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38(4):387–395CrossRef
2.
go back to reference Pilgaard K, Jensen CB, Schou JH et al (2009) The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia 52(7):1298–1307CrossRefPubMed Pilgaard K, Jensen CB, Schou JH et al (2009) The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia 52(7):1298–1307CrossRefPubMed
3.
go back to reference Vilsbøll T, Krarup T, Madsbad S, Holst J (2002) Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients. Diabetologia 45(8):1111–1119CrossRefPubMed Vilsbøll T, Krarup T, Madsbad S, Holst J (2002) Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients. Diabetologia 45(8):1111–1119CrossRefPubMed
4.
go back to reference Mensink RP, Sanders TA, Baer DJ et al (2016) The increasing use of interesterified lipids in the food supply and their effects on health parameters. Adv Nutr 7(4):719–729CrossRefPubMedPubMedCentral Mensink RP, Sanders TA, Baer DJ et al (2016) The increasing use of interesterified lipids in the food supply and their effects on health parameters. Adv Nutr 7(4):719–729CrossRefPubMedPubMedCentral
5.
go back to reference Asif M (2011) Process advantages and product benefits of interesterification in oils and fats. Int J Nutr Pharmacol Neurological Dis 1:134–138CrossRef Asif M (2011) Process advantages and product benefits of interesterification in oils and fats. Int J Nutr Pharmacol Neurological Dis 1:134–138CrossRef
6.
go back to reference Idris NA, Dian NL (2005) Inter-esterified palm products as alternatives to hydrogenation. Asia Pac J Clin Nutr 14(4):396–401PubMed Idris NA, Dian NL (2005) Inter-esterified palm products as alternatives to hydrogenation. Asia Pac J Clin Nutr 14(4):396–401PubMed
7.
go back to reference Berry SEE (2009) Triacylglycerol structure and interesterification of palmitic and stearic acid-rich fats: an overview and implications for cardiovascular disease. Nutr Res Rev 22(01):3–17CrossRefPubMed Berry SEE (2009) Triacylglycerol structure and interesterification of palmitic and stearic acid-rich fats: an overview and implications for cardiovascular disease. Nutr Res Rev 22(01):3–17CrossRefPubMed
8.
go back to reference Sanders TAB, Filippou A, Berry SE, Baumgartner S, Mensink RP (2011) Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am J Clin Nutr 94(6):1433–1441CrossRefPubMed Sanders TAB, Filippou A, Berry SE, Baumgartner S, Mensink RP (2011) Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am J Clin Nutr 94(6):1433–1441CrossRefPubMed
9.
go back to reference Filippou A, Teng KT, Berry SE, Sanders TA (2014) Palmitic acid in the sn-2 position of dietary triacylglycerols does not affect insulin secretion or glucose homeostasis in healthy men and women. Eur J Clin Nutr 68(9):1036–1041CrossRefPubMedPubMedCentral Filippou A, Teng KT, Berry SE, Sanders TA (2014) Palmitic acid in the sn-2 position of dietary triacylglycerols does not affect insulin secretion or glucose homeostasis in healthy men and women. Eur J Clin Nutr 68(9):1036–1041CrossRefPubMedPubMedCentral
10.
go back to reference Sanders TA, Filippou A, Berry SE, Baumgartner S, Mensink RP (2011) Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am J Clin Nutr 94(6):1433–1441CrossRefPubMed Sanders TA, Filippou A, Berry SE, Baumgartner S, Mensink RP (2011) Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am J Clin Nutr 94(6):1433–1441CrossRefPubMed
11.
go back to reference CPG Secretariat (2015) Management of type 2 diabetes mellitus in clinical practice guidelines. Ministry of Health Malaysia, Putrajaya CPG Secretariat (2015) Management of type 2 diabetes mellitus in clinical practice guidelines. Ministry of Health Malaysia, Putrajaya
12.
go back to reference Mo S-Y, Teng K-T, Nesaretnam K, Lai O-M (2015) Similar physical characteristics but distinguishable sn-2 palmitic acid content and reduced solid fat content of chemically interesterified palm olein compared with native palm olein by dry fractionation: a lab-scale study. Eur J Lipid Sci Tech 118:1389–1398CrossRef Mo S-Y, Teng K-T, Nesaretnam K, Lai O-M (2015) Similar physical characteristics but distinguishable sn-2 palmitic acid content and reduced solid fat content of chemically interesterified palm olein compared with native palm olein by dry fractionation: a lab-scale study. Eur J Lipid Sci Tech 118:1389–1398CrossRef
13.
go back to reference Alberti KGMM., Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med 15(7):539–553CrossRef Alberti KGMM., Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med 15(7):539–553CrossRef
14.
go back to reference Young VM, Toborek M, Yang F, McClain CJ, Hennig B (1998) Effect of linoleic acid on endothelial cell inflammatory mediators. Metabolism 47(5):566–572CrossRefPubMed Young VM, Toborek M, Yang F, McClain CJ, Hennig B (1998) Effect of linoleic acid on endothelial cell inflammatory mediators. Metabolism 47(5):566–572CrossRefPubMed
15.
go back to reference Dian NLHM., Sundram K, Idris NA (2007) Effect of chemical interesterification on triacylglycerol and solid fat contents of palm stearin, sunflower oil and palm kernel olein blends. Eur J Lipid Sci Tech 109(2):147–156CrossRef Dian NLHM., Sundram K, Idris NA (2007) Effect of chemical interesterification on triacylglycerol and solid fat contents of palm stearin, sunflower oil and palm kernel olein blends. Eur J Lipid Sci Tech 109(2):147–156CrossRef
16.
go back to reference MPOB (2004) Determination of slip melting point. In: MPOB official test methods. Malaysian Palm Oil Board, Bangi, Selangor (Malaysia). (Test Method pp 4.2) MPOB (2004) Determination of slip melting point. In: MPOB official test methods. Malaysian Palm Oil Board, Bangi, Selangor (Malaysia). (Test Method pp 4.2)
17.
go back to reference Norizzah AR, Chong CL, Cheow CS, Zaliha O (2004) Effects of chemical interesterification on physicochemical properties of palm stearin and palm kernel olein blends. Food Chem 86(2):229–235CrossRef Norizzah AR, Chong CL, Cheow CS, Zaliha O (2004) Effects of chemical interesterification on physicochemical properties of palm stearin and palm kernel olein blends. Food Chem 86(2):229–235CrossRef
18.
go back to reference Zampelas A, Williams CM, Morgan LM, Wright J, Quinlan PT (1994) The effect of triacylglycerol fatty acid positional distribution on postprandial plasma metabolite and hormone responses in normal adult men. Br J Nutr 71(03):401–410CrossRefPubMed Zampelas A, Williams CM, Morgan LM, Wright J, Quinlan PT (1994) The effect of triacylglycerol fatty acid positional distribution on postprandial plasma metabolite and hormone responses in normal adult men. Br J Nutr 71(03):401–410CrossRefPubMed
19.
go back to reference Berry SEE, Miller GJ, Sanders TAB (2007) The solid fat content of stearic acid-rich fats determines their postprandial effects. Am J Clin Nutr 85(6):1486–1494CrossRefPubMed Berry SEE, Miller GJ, Sanders TAB (2007) The solid fat content of stearic acid-rich fats determines their postprandial effects. Am J Clin Nutr 85(6):1486–1494CrossRefPubMed
20.
go back to reference Fernández-García JC, Murri M, Coin-Aragüez L, Alcaide J, El Bekay R, Tinahones FJ (2014) GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects. Clin Endocrinol 80(5):671–676CrossRef Fernández-García JC, Murri M, Coin-Aragüez L, Alcaide J, El Bekay R, Tinahones FJ (2014) GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects. Clin Endocrinol 80(5):671–676CrossRef
21.
go back to reference Ahrén B (2009) Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin—diabetes control and potential adverse events. Best Prac Res Clin Endocrinol Metab 23(4):487–498CrossRef Ahrén B (2009) Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin—diabetes control and potential adverse events. Best Prac Res Clin Endocrinol Metab 23(4):487–498CrossRef
22.
go back to reference Vilsbøll T, Holst JJ (2004) Incretins, insulin secretion and type 2 diabetes mellitus. Diabetologia 47(3):357–366CrossRefPubMed Vilsbøll T, Holst JJ (2004) Incretins, insulin secretion and type 2 diabetes mellitus. Diabetologia 47(3):357–366CrossRefPubMed
23.
go back to reference Summers LKM, Fielding BA, Ilic V, Quinlan PT, Frayn KN (1998) The effect of triacylglycerol-fatty acid positional distribution on postprandial metabolism in subcutaneous adipose tissue. Br J Nutr 79(02):141–147CrossRefPubMed Summers LKM, Fielding BA, Ilic V, Quinlan PT, Frayn KN (1998) The effect of triacylglycerol-fatty acid positional distribution on postprandial metabolism in subcutaneous adipose tissue. Br J Nutr 79(02):141–147CrossRefPubMed
24.
go back to reference Berry SEE, Woodward R, Yeoh C, Miller GJ, Sanders TAB (2007) Effect of interesterification of palmitic acid-rich triacylglycerol on postprandial lipid and factor VII response. Lipids 42(4):315–323CrossRefPubMed Berry SEE, Woodward R, Yeoh C, Miller GJ, Sanders TAB (2007) Effect of interesterification of palmitic acid-rich triacylglycerol on postprandial lipid and factor VII response. Lipids 42(4):315–323CrossRefPubMed
25.
go back to reference Filippou A, Berry SE, Baumgartner S, Mensink RP, Sanders TAB (2014) Palmitic acid in the sn-2 position decreases glucose-dependent insulinotropic polypeptide secretion in healthy adults. Eur J Clin Nutr 68(5):549–554CrossRefPubMed Filippou A, Berry SE, Baumgartner S, Mensink RP, Sanders TAB (2014) Palmitic acid in the sn-2 position decreases glucose-dependent insulinotropic polypeptide secretion in healthy adults. Eur J Clin Nutr 68(5):549–554CrossRefPubMed
26.
go back to reference Yli-Jokipii K, Kallio H, Schwab U, Mykkänen H, Kurvinen J-P, Savolainen MJ (2001) Effects of palm oil and transesterified palm oil on chylomicron and VLDL triacylglycerol structures and postprandial lipid response. J Lipid Res 42(10):1618–1625PubMed Yli-Jokipii K, Kallio H, Schwab U, Mykkänen H, Kurvinen J-P, Savolainen MJ (2001) Effects of palm oil and transesterified palm oil on chylomicron and VLDL triacylglycerol structures and postprandial lipid response. J Lipid Res 42(10):1618–1625PubMed
27.
go back to reference Maljaars J, Romeyn EA, Haddeman E, Peters HP, Masclee AA (2009) Effect of fat saturation on satiety, hormone release, and food intake. Am J Clin Nutr 89(4):1019–1024CrossRefPubMed Maljaars J, Romeyn EA, Haddeman E, Peters HP, Masclee AA (2009) Effect of fat saturation on satiety, hormone release, and food intake. Am J Clin Nutr 89(4):1019–1024CrossRefPubMed
28.
go back to reference Migoya EM, Bergeron R, Miller JL et al (2010) Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther 88(6):801–808CrossRefPubMed Migoya EM, Bergeron R, Miller JL et al (2010) Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther 88(6):801–808CrossRefPubMed
29.
go back to reference Brennan IM, Feltrin KL, Nair NS et al (2009) Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women. Am J Physiol Gastrointest Liver Physiol 297(3):G602-G610CrossRef Brennan IM, Feltrin KL, Nair NS et al (2009) Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women. Am J Physiol Gastrointest Liver Physiol 297(3):G602-G610CrossRef
Metadata
Title
Interesterified palm olein lowers postprandial glucose-dependent insulinotropic polypeptide response in type 2 diabetes
Authors
Shuen-Yeing Mo
Oi-Ming Lai
Boon-How Chew
Ruhaini Ismail
Sallehudin Abu Bakar
Norli Abdul Jabbar
Kim-Tiu Teng
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 5/2019
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-018-1738-6

Other articles of this Issue 5/2019

European Journal of Nutrition 5/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.